Cargando…
Limited AT1 Receptor Internalization Is a Novel Mechanism Underlying Sustained Vasoconstriction Induced by AT1 Receptor Autoantibody From Preeclampsia
BACKGROUND: Angiotensin II type 1 receptor (AT (1)R) autoantibody (AT1‐AA) was first identified as a causative factor in preeclampsia. Unlike physiological ligand angiotensin II (Ang II), AT1‐AA can induce vasoconstriction in a sustained manner, causing a series of adverse effects, such as vascular...
Autores principales: | Bian, Jingwei, Lei, Jinghui, Yin, Xiaochen, Wang, Pengli, Wu, Ye, Yang, Xiaoli, Wang, Li, Zhang, Suli, Liu, Huirong, Fu, Michael L. X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475063/ https://www.ncbi.nlm.nih.gov/pubmed/30845870 http://dx.doi.org/10.1161/JAHA.118.011179 |
Ejemplares similares
-
The Prognostic Role of Angiotensin II Type 1 Receptor Autoantibody in Non-Gravid Hypertension and Pre-eclampsia: A Meta-analysis and Our Studies
por: Lei, Jinghui, et al.
Publicado: (2016) -
Autoantibodies against AT1 Receptor Contribute to Vascular Aging and Endothelial Cell Senescence
por: Wang, Meili, et al.
Publicado: (2019) -
Biased activation of β(2)-AR/Gi/GRK2 signal pathway attenuated β(1)-AR sustained activation induced by β(1)-adrenergic receptor autoantibody
por: Chen, Hao, et al.
Publicado: (2021) -
Large‐Conductance Calcium‐Activated Potassium Channel Opener, NS1619, Protects Against Mesenteric Artery Remodeling Induced by Agonistic Autoantibodies Against the Angiotensin II Type 1 Receptor
por: Wang, Meili, et al.
Publicado: (2022) -
Association of Angiotensin Receptor Autoantibodies With Cardiovascular Abnormalities in Preeclampsia
por: Minhas, Anum S., et al.
Publicado: (2021)